27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
Shares of Arrowhead Pharmaceuticals (NASDAQ:ARWR) were flat in after-market trading after the company reported Q3 results.
Quarterly Results
Earnings per share were down 123.08% year over year to ($0.29), which missed the estimate of ($0.20).
Revenue of $45,891,000 rose by 67.63% from the same period last year, which beat the estimate of $37,520,000.
Looking Ahead
Earnings guidance hasn't been issued by the company for now.
Arrowhead Pharmaceuticals hasn't issued any revenue guidance for the time being.
Conference Call Details
Date: Aug 05, 2021
Time: 04:30 PM
ET Webcast URL: https://edge.media-server.com/mmc/p/uikmqr9b
Recent Stock Performance
52-week high: $93.66
52-week low: $32.86
Price action over last quarter: Up 2.38%
Company Profile
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!